Skip to main content

Table 2 The characteristics of patients with prostate cancer from the clinic database with values of PSA before and after treatment, number of treatments, duration of treatments and percentage of improvement

From: Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients

Type of cancer Grade, score PSA before PSA after Days of treatment Number of treatments Percentage of improvement
Prostate Gleason score - 6-9 1507 46 531 98 96.9
Prostate Grade II-III; Stage B2 116 3.7 302 7 96.8
Prostate ND 788 21.1 112 15 97.3
Prostate Gleason score 2.5 54 12.3 343 32 77.2
Prostate ND 35.8 1 89 10 97.2
Prostate Gleason 7 48.8 5.8 4863 18 88.1
Prostate Gleason score 6 44 2.7 161 20 93.9
Prostate Gleason score 9 5.1 71.2 143 33 −1296.1
Prostate ND 65 184 588 13 −183.1
Prostate Gleason score 4 26 5.5 146 5 78.8
Prostate Gleason score 4 63 0.5 112 7 99.2
Prostate Gleason score 5 20 2.3 214 6 88.5
Prostate ND 153 87 247 4 43.1
Prostate ND 7.3 2.3 136 8 68.5
Prostate Gleason score 6 11 8 887 42 27.3
Prostate, metastatic ND 51.3 21 500 32 59.1
Prostate, metastatic ND 21 37.1 139 52 −76.7
Prostate Gleason score 8 8 0.1 481 28 98.8
Prostate ND 14.6 36.2 1652 81 −147.9
Prostate Gleason score 6 11 29 1000 11 −163.6
Prostate, metastatic ND 28.6 86.9 89 24 −203.8
Prostate Gleason score 6-8 48.8 1.2 121 15 97.5
Prostate Gleason score 6 65.2 13.8 45 4 78.8
Prostate Gleason score 6-8 106 86.5 310 11 18.4
Prostate, metastatic Stage II 500 54.3 542 77 89.1
Prostate Gleason score 6.5, stage II 10.6 7.5 643 27 29.2